Last updated on March 2018

Incidence of Dyssynchronies in Early ARDS


Brief description of study

Patients sedated under mechanical ventilation with acute hypoxemic respiratory failure with a PaO2/FiO2 equal or less than 200mmHg (Acute Respiratory Distress Syndrome, ARDS and non-ARDS) will be included in the study early in the course of the disease (first week of mechanical ventilation). At enrollment, data on the clinical condition of the patient will be recorded together with ventilation settings: ventilation mode, the fraction of inspired oxygen (FiO2), PEEP, tidal volume, set pressure, respiratory rate, time of the respiratory cycle, recent blood gas parameters.

Airway pressure, flow, and esophageal pressure (or alternatively electrical activity of the diaphragm, Eadi) will be recorded 3 times a day for 7 days:

  1. Period 1 (morning): duration 20-30 minutes
  2. Period 2 (afternoon): duration 20-30 minutes
  3. Period 3 (evening / night): duration 20-30 minutes

Registration will be ended at extubation, death or at eight days from the first recording.

Monitoring of vital parameters (hemodynamic and respiratory) will be continuous throughout the duration of the study, as per normal clinical practice. All drugs used during the day of the measurements will be recorded. The patient will then be followed until discharge from the ICU and after 60 days of discharge to evaluate mortality.

The analysis of the recorded waveforms will be performed in a single center by a centralized system that will quantify dyssynchrony and its intensity, calculate pressure time product, collect clinical and physiological data and outcome, and investigate possible correlations.

Detailed Study Description

Measurements

Physiological measurements Airway pressure, esophageal pressure, electrical activity of the diaphragm and flow

  1. Flow and airway pressure signal will be recorded from the ventilators by connecting the ventilator to a laptop computer if possible. Recording these data simultaneously with esophageal pressure or electrical activity of the diaphragm (see later in protocol for details) could be technically unfeasible. In this case, a flow sensor and an additional port for pressure measurement will be connected to the endotracheal tube proximal to the Y connector (without interfering with patient's breathing). Both, flow sensor and pressure port will be connected to differential pressure transducers respectively. Signals will be acquired with at least 100 Hz sampling.
  2. In centers used to perform esophageal pressure measurements, an esophageal catheter will be inserted as per usual clinical practice, checked for accuracy with an occlusion test, and connected to a 3 ways stopcock and a pressure transducer. The occlusion test will be recorded and performed before any new recordings. Any ventilator can be used if an esophageal pressure is used.
  3. If available, in centers used to record or monitor the electrical activity of the diaphragm, instead of an esophageal catheter, the electrical activity of the diaphragm will be provided by a catheter dedicated to the monitoring of the electrical activity of the diaphragm, or EaDi, on a Servo-I or Servo-U ventilator (Maquet, Lund, Sweden). This catheter is formally designed to be used for a specific mode of ventilation called Neurally Adjusted Ventilatory Assist (NAVA) but here will be used for monitoring purposes only (NAVA catheter). In such cases a specific software (Servotracker, Maquet) may be used to record all signals from the ventilator.
  4. In case the patient has been enrolled but the esophageal catheter cannot be placed or is contraindicated, the recordings will be limited to airway pressure and flow. Each centre should have a minimum of 5 patients with esophageal catheter or electrical activity recording.
  5. Occlusion pressure (or pressure at 0.1 sec, P0.1) as an index of respiratory drive. In patients triggering the ventilator, the P0.1 will be analyzed from the tracings. The only condition to have reliable measurements is to use a pressure triggering, not a flow triggering.

Data collection

At the beginning of the recordings, ventilatory settings will be collected: ventilator brand, mode of ventilation and settings including: FiO2, PEEP, set and real tidal volume (or pressure), set and real respiratory rate, maximum inspiratory flow, inspiratory time, Glasgow coma scale and Richmond Agitation Sedation Scale (RASS) or Riker Sedation Agitation Scale (SAS). Any medications used at the day of the measurement and before will be collected especially neuromuscular blocking agents, sedatives (brands and doses), opiates and vasopressors including dose, duration of the treatment and date of last use. Investigators will also collect clinical characteristics of the patients (SAPS and SOFA at ICU admission and at the day of the recording, main ARDS or AHRF etiology and risk factors, age, gender, weight, height, days of mechanical ventilation, patient's position -supine vs prone-, kidney and liver function). Other comorbidities will be recorded, with special emphasis in the ones that could affect the incidence of the studied phenomenon, such as: COPD, lung transplant or any neuromuscular condition that could affect the respiratory drive or respiratory muscle function.

Patients will be followed up to get the total duration of mechanical ventilation, ICU length of stay, day of the first weaning attempt, day of tracheotomy if any, status at ICU discharge (alive or death) and at hospital discharge and at day 60.

Clinical Study Identifier: NCT03447288

Contact Investigators or Research Sites near you

Start Over

Tài Pham, Md, PhD

St Michael's hospital
Toronto, ON Canada
  Connect »

Ewan C. Goligher, MD, FRCP(C)

Toronto General Hospital
Toronto, ON Canada
  Connect »

Jian-Xin Zhou, MD

Beijing Tiantan Hospital, Capital Medical University
Beijing, China
  Connect »

Alain Mercat, MD

Centre Hospitalier Universitaire - CHU Angers
Angers, France
  Connect »

Tobias Besher, MD

Universit tsklinikum Schleswig-Holstein
Kiel, Germany
  Connect »

Dimitris Georgopoulos, MD

University Hospital of Heraklion
Heraklion, Greece
  Connect »

Savino Spadaro, MD

University of Ferrara
Ferrara, Italy
  Connect »

Gilda Cinnella, MD

Azienda Ospedaliero - Universitaria OORR Ospedali Riuniti di Foggia
Foggia, Italy
  Connect »

Davide Chiumello, Pr.

ASST Santi Paolo e Carlo
Milano, Italy
  Connect »

Tommaso Mauri, MD

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milano, Italy
  Connect »

Leo Heunks, Pr.

VU University Medical Centre Amsterdam
Amsterdam, Netherlands
  Connect »

Oriol Roca, MD

Vall d'Hebron University Hospital
Barcelona, Spain
  Connect »

cwchen chen, MD

National Cheng-Kung University and Hospital
Tainan City, Taiwan
  Connect »

Nuttapol Rittayamai, MD

Siriraj Hospital
Bangkok, Thailand
  Connect »